FIELD: medicine.
SUBSTANCE: invention relates to an application of a combination of an EZH2 inhibitor and a BTK inhibitor in production of a medicinal product for treating a tumour, differs in that the EZH2 inhibitor constitutes a compound by the formula (IE) or a pharmacologically acceptable salt thereof, the BTK inhibitor constitutes a compound by the formula (IIA) or a pharmacologically acceptable salt thereof, wherein the tumour is selected from the group consisting of diffuse B-large cell lymphoma and follicular lymphoma.
EFFECT: application of an EZH2 inhibitor and a BTK inhibitor in treatment of tumours.
7 cl, 5 dwg, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCTION OF BENZOFURAN DERIVATIVE | 2018 |
|
RU2777624C2 |
| BENZOFURAN DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2016 |
|
RU2727198C2 |
| HUMAN EZH2 INHIBITORS AND METHODS FOR USE THEREOF | 2013 |
|
RU2704445C2 |
| COMBINED THERAPY FOR CANCER TREATMENT | 2013 |
|
RU2699546C2 |
| BENZAMIDE COMPOUNDS | 2019 |
|
RU2801647C2 |
| METHODS OF TREATING CANCER | 2013 |
|
RU2677276C2 |
| SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
| AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
| SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
| N- (PHENYLSULPHONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2744358C2 |
